Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery
Maintenance of Anticoagulant and Antiplatelet Agents for Patients Undergoing Vitreoretinal Surgery
1 other identifier
observational
206
1 country
1
Brief Summary
Purpose: To establish the prevalence of anticoagulant, aspirin, and clopidogrel use in patients undergoing vitreoretinal surgery, and to compare the outcome of peribulbar anesthesia between users and non-users.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 24, 2009
CompletedFirst Posted
Study publicly available on registry
November 25, 2009
CompletedNovember 25, 2009
November 1, 2009
5 months
November 24, 2009
November 24, 2009
Conditions
Keywords
Study Arms (7)
group 1
patients with no anticoagulants used as the control group
group 2
patients treated with anticoagulant therapy (warfarin, fluindone, acenocoumarol)
group 3
patients treated with aspirin
group 4
patients treated with clopidogrel therapy
group 5
patients treated with both anticoagulant and aspirin medications
group 6
patients treated with both anticoagulant and clopidogrel medications
group 7
patients treated with both aspirin and clopidogrel medications
Eligibility Criteria
We analyzed the chart of 239 eyes (206 patients) which underwent posterior segment surgery with peribulbar anesthesia.
You may qualify if:
- Take or no anticoagulant treatment before surgery,
- Vitreoretinal surgery
You may not qualify if:
- No surgery
- Anesthetic complication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ophthalmology Unit CHU Dijon
Dijon, Burgundy, 21000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 24, 2009
First Posted
November 25, 2009
Study Start
January 1, 2009
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
November 25, 2009
Record last verified: 2009-11